New registry aims to perfect heart ablation workflow
NCT ID NCT06656884
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry is collecting data from over 500 patients with atrial fibrillation who are treated with the FARAPULSE ablation system in routine care. The goal is to identify which pre-procedure, procedure, and follow-up steps work best for different types of patients. Researchers will look at how patient characteristics, procedure choices, and safety events relate to long-term success.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FARAPULSE Pulsed Field Ablation System
What this could lead to
If successful, this study could help doctors standardize the best way to use the FARAPULSE device for treating atrial fibrillation, potentially improving patient outcomes.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may vary across hospitals and patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
A.o. Krankenhaus der Elisabethinen Linz
Linz, Austria
-
Azienda Ospedaliera San Gerardo
Monza, Italy
-
Azienda Ospedaliero-Universitaria di Ferrara
Ferrara, Italy
-
CHR de la Citadelle
Namur, Belgium
-
CHRU Hopital Trousseau
Tours, France
-
CHU de Bordeaux
Bordeaux, France
-
Freeman Hospital
Newcastle upon Tyne, United Kingdom
-
GHP Arytmi Center Stockholm
Stockholm, Sweden
-
Glenfield Hospital
Leicester, United Kingdom
-
Hopital Saint Philibert
Lomme, France
-
Hospital De La Santa Creu I Sant Pau
Barcelona, Spain
-
Hospital Universitario Nuestra Senora de Candelaria
Santa Cruz de Tenerife, Spain
-
Hospital de Navarra
Pamplona, Spain
-
Ippokrateio General Hospital of Athens
Athens, Greece
-
King Fahd Armed Forces Hospital
Jeddah, Saudi Arabia
-
Mitera Hospital
Athens, Greece
-
Munchen Klinik Bogenhausen
München, Germany
-
Ospedale Dell Angelo
Mestre, Italy
-
Ospedale San Bortolo di Vicenza Azienda ULSS 8 Berica
Vicenza, Italy
-
Ospedale di Rivoli
Rivoli, Italy
-
Papworth Hospital
Cambridge, United Kingdom
-
Royal Bournemouth Hospital
Bournemouth, United Kingdom
-
Southampton University Hospital
Southampton, United Kingdom
-
Staedtisches Klinikum Karlsruhe
Karlsruhe, Germany
-
Universitaetsklinikum Dusseldorf
Düsseldorf, Germany
-
University Hospital Virgen Arrixaca
El Palmar, Spain
-
Ziekenhuis Oost-Limburg
Genk, Belgium
-
Ziekenhuis aan de Stroom, Middelheim
Antwerp, Belgium